Dr. Oh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10903 New Hampshire Avenue
Silver Spring, MD 20993- Is this information wrong?
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1997 - 2000
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1994 - 1996
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1994
- George Washington UniversityResidency, Surgery, 1989 - 1992
- Butler HospitalInternship, Transitional Year, 1988 - 1989
- The Warren Alpert Medical School of Brown UniversityClass of 1988
- Yale UniversityBA
Certifications & Licensure
- MD State Medical License 2008 - 2025
- VA State Medical License 2017 - 2020
- DC State Medical License 1992 - 2020
- TX State Medical License 2001 - 2010
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2013
- Clifton Howe Award for clinical excellence 1998
Clinical Trials
- Mode of Dialysis Therapy and Outcomes in End Stage Renal Disease (ESRD) Start of enrollment: 2009 Jul 01
Publications & Presentations
PubMed
- 22 citationsRandomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–...Pasi A. Jänne, Luis Paz-Ares, Yun Oh, C. Eschbach, Vera Hirsh, Nathan Enas, Leslie Brail, Joachim von Pawel> ;Journal of Thoracic Oncology. 2014 Jan 1
- 18 citationsPharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patie...Hai T. Tran, Ralph Zinner, George R. Blumenschein, Y. Oh, Vassiliki A. Papadimitrakopoulou, Edward S. Kim, Charles Lu, Mubashira Malik, Bert L. Lum, Roy S. Herbst> ;Investigational New Drugs. 2011 Jun 1
- 93 citationsNumber of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastasesYun Oh, Sarah H. Taylor, Benjamin N. Bekele, J. Matthew Debnam, Pamela K. Allen, Dima Suki, Raymond Sawaya, Ritsuko Komaki, David J. Stewart, Daniel D. Karp> ;Cancer. 2009 Jul 1
- Join now to see all
Books/Book Chapters
Committees
- Chair, Glioblastoma Astrocytoma ETP's (Evidence Based Treatment Protocols) for CCE 2012 - Present
- Chair, Melanoma ETP's (Evidence Based Treatment Protocols) for CCE 2012 - Present
- Co-chair, Lung Cancer ETP's (Evidence Based Treatment Protocol) for CCE 2011 - Present
- Chair, Head & Neck Cancer ETP's (Evidence Based Treatment Protocols) for CCE 2011 - Present
- member, Clinical Quality Control Committee for CCE (Cancer Centers of Excellence) 2009 - Present
- volunteer, Minority Health Fair - Asian American Center of Frederick, under Ms. Elizabeth Chung 2009 - Present
Other Languages
- Korean, Spanish, French
Hospital Affiliations
- Frederick HealthFrederick, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: